Comparative Study of Two Recombinant Human Erythropoietin Products on Chronic Kidney Disease Patients
Conditions: Anemia of Chronic Kidney Disease Interventions: Biological: Experimental: Epoetin alfa Megalabs ® Erythropoietin injectable in intravenous administration.; Biological: Active comparator: European Union licenced epoetin alfa Sponsors: Megalabs; Azidus Laboratories Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2024 Category: Research Source Type: clinical trials
Pharmacokinetic/Pharmacodynamic Study of 3 Subcutaneous Single Dose Epoetin Alfa Formulations in Healthy Volunteers
Condition: Anemia Intervention: Drug: Epoetin Alfa 40000 UNT/ML Sponsor: Bio Sidus SA Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2019 Category: Research Source Type: clinical trials
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa
Conditions: Anemia; Dialysis-dependent Chronic Kidney Disease Interventions: Drug: Vadadustat; Drug: Epoetin Alfa; Drug: Vadadustat TIW Sponsor: Akebia Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2019 Category: Research Source Type: clinical trials
